Condition
Genetic Predisposition to Cancer
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Recruiting2
Active Not Recruiting1
Enrolling By Invitation1
Clinical Trials (4)
Showing 4 of 4 trials
NCT00001163Active Not Recruiting
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT05350761Recruiting
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT06792721Recruiting
MEASUREMENT OF CIRCULATING MUTATION BURDEN
NCT06800599Enrolling By InvitationPrimary
Single-institution Register of Individuals Undergoing Cancer Genetic Risk Assessment
Showing all 4 trials